J&J Announces EU Regulatory Approval for Actelion Deal

by Zacks Equity Research Published on June 12,2017

Johnson & Johnson (JNJ) has received a regulatory approval from the European Commission (EC), thus completing all necessary formalities to close the pending acquisition of Swiss biopharmaceutical company, Actelion Ltd.

• JNJ Quick QuoteJNJPositive Net Change
• REGN Quick QuoteREGNNegative Net Change
• VVUS Quick QuoteVVUSPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss

by Zacks Equity Research Published on April 27,2017

United Therapeutics Corporation (UTHR) reported adjusted earnings of $3.89 per share (including stock-based compensation benefit) for the first quarter of 2017

• MDT Quick QuoteMDTNegative Net Change
• GILD Quick QuoteGILDPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• UTHR Quick QuoteUTHRPositive Net Change

After Johnson & Johnson Earnings, Buy These Pharma Stocks

by Ryan McQueeney Published on April 18,2017

Shares of Johnson & Johnson (JNJ) slid nearly 3.5% in morning trading Tuesday after the pharma giant's first-quarter earnings results were met with mixed reactions from investors. As the sell-off continues, investors focused on large-cap pharma companies may want to move their money into stronger options this earnings season.

• RHHBY Quick QuoteRHHBYPositive Net Change
• SNY Quick QuoteSNYNegative Net Change
• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down

by Zacks Equity Research Published on April 18,2017

Johnson & Johnson (JNJ) reported mixed first quarter results, with earnings beating expectations while sales missing the same.

• PFE Quick QuotePFEPositive Net Change
• JNJ Quick QuoteJNJPositive Net Change
• MRK Quick QuoteMRKNegative Net Change
• ALIOF Quick QuoteALIOFNo Net Change

United Therapeutics Tanks, Remodulin Pump Launch Delayed

by Zacks Equity Research Published on April 04,2017

United Therapeutics Corporation (UTHR) shares plunged around 9% on Monday after the company announced that regulatory issues will delay the planned U.S. launch of RemoSynch - an implantable pump for delivering Remodulin

• LLY Quick QuoteLLYPositive Net Change
• MDT Quick QuoteMDTNegative Net Change
• UTHR Quick QuoteUTHRPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss

by Zacks Equity Research Published on February 23,2017

United Therapeutics Corporation (UTHR) reported adjusted earnings of $2.64 per share for fourth-quarter 2016, which missed the Zacks Consensus Estimate of $3.62 by 27.1%.

• MDT Quick QuoteMDTNegative Net Change
• GILD Quick QuoteGILDPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• UTHR Quick QuoteUTHRPositive Net Change

4 Drug Stocks that are Broker Favorites

by Arpita Dutt Published on February 07,2017

Here's a look at 4 drug stocks preferred by analysts who have a deep knowledge and understanding of the industry and its companies.

• JNJ Quick QuoteJNJPositive Net Change
• CELG Quick QuoteCELGPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• EXEL Quick QuoteEXELNegative Net Change

J&J to Acquire Actelion for $30B: Is It a Strategic Fit?

by Zacks Equity Research Published on January 27,2017

Johnson & Johnson (JNJ) entered into a definitive agreement to acquire Actelion (ALIOF) for $280 per share, as of Jan 25, 2017, in an all-cash transaction.

• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• ANIK Quick QuoteANIKPositive Net Change
• SNSS Quick QuoteSNSSPositive Net Change

Biotech Stock Roundup: Synergy Drug Gets FDA Nod, AbbVie, GILD HCV Drugs under EU Review

by Arpita Dutt Published on January 25,2017

There were quite a few updates on the regulatory front this week in the biotech sector including FDA approval for Synergy's (SGYP) drug.

• VRTX Quick QuoteVRTXPositive Net Change
• REGN Quick QuoteREGNNegative Net Change
• GILD Quick QuoteGILDPositive Net Change
• CELG Quick QuoteCELGPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

J&J (JNJ) Q4 Earnings Top; Seeks Options for Diabetes Unit

by Zacks Equity Research Published on January 24,2017

Johnson & Johnson (JNJ) reported a mixed quarter with earnings beating expectations while sales missing the same.

• PFE Quick QuotePFEPositive Net Change
• JNJ Quick QuoteJNJPositive Net Change
• MRK Quick QuoteMRKNegative Net Change
• ALIOF Quick QuoteALIOFNo Net Change

5 Best Performing Healthcare Mutual Funds of 2016

by Zacks Equity Research Published on January 23,2017

Investors rely on the healthcare firms to safeguard their investments as demand for its services does not vary much with market conditions

• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• ARIA Quick QuoteARIAPositive Net Change
• TKPYY Quick QuoteTKPYYNo Net Change
• FSPHX Quick QuoteFSPHXPositive Net Change

J&J Arm Buys Megadyne, Boosts Electrosurgical Tools Portfolio

by Zacks Equity Research Published on January 23,2017

Ethicon Endo-Surgery, Inc. a subsidiary of Johnson & Johnson (JNJ), announced the acquisition of Megadyne Medical Products, Inc., a privately held medical device company.

• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• ENZ Quick QuoteENZPositive Net Change
• ACHN Quick QuoteACHNNegative Net Change

VIVUS Licenses Rights to PAH Drugs from Selten Pharma

by Zacks Equity Research Published on January 11,2017

VIVUS, Inc. (VVUS) acquired exclusive global rights to develop and commercialize pulmonary arterial hypertension (PAH) drugs, tacrolimus and ascomycin from private biotech company, Selten Pharma, Inc.

• VVUS Quick QuoteVVUSPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• ARNA Quick QuoteARNAPositive Net Change
• UTHR Quick QuoteUTHRPositive Net Change

4 Stocks in Focus as Biotech M&A Hopes Surge on Takeda-ARIAD Deal

by Arpita Dutt Published on January 10,2017

Takeda to Buy ARIAD, More M&As to Follow in Biotech Sector?

• ALIOF Quick QuoteALIOFNo Net Change
• INCY Quick QuoteINCYNegative Net Change
• EXEL Quick QuoteEXELNegative Net Change
• KITE Quick QuoteKITENegative Net Change

United Therapeutics' PAH Suite Bodes Well, Competition Rife

by Zacks Equity Research Published on December 29,2016

On Dec 29, 2016, we issued an updated report on United Therapeutics Corporation (UTHR).

• MDT Quick QuoteMDTNegative Net Change
• GILD Quick QuoteGILDPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• UTHR Quick QuoteUTHRPositive Net Change

J&J Resumes Talks with Actelion: Did Sanofi Just Lose Out?

by Zacks Equity Research Published on December 22,2016

In an interesting turn of events, Johnson & Johnson (JNJ) announced that it is once again discussing a possible transaction with Swiss biotechnology company Actelion Ltd. (ALIOF).

• SNY Quick QuoteSNYNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug

by Arpita Dutt Published on December 21,2016

Biotech stocks like Conatus (CNAT) and Clovis reported positive developments this week with one company signing a deal and the other getting accelerated FDA approval for its cancer treatment.

• ALXN Quick QuoteALXNPositive Net Change
• GILD Quick QuoteGILDPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• BIIB Quick QuoteBIIBNegative Net Change

Company News for December 15, 2016

by Zacks Equity Research Published on December 15,2016

Companies In The News are: ABM,JNJ,ALIOF,HTZ,VRX

• ABM Quick QuoteABMPositive Net Change
• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

J&J (JNJ) Ends Deal Talks with Actelion: Will Sanofi Gain?

by Zacks Equity Research Published on December 14,2016

On Tuesday, Johnson & Johnson (JNJ) announced that it has ended talks regarding a possible transaction with Swiss biotechnology company, Actelion Ltd. (ALIOF), reportedly for a disagreement over the purchase price.

• SNY Quick QuoteSNYNegative Net Change
• PFE Quick QuotePFEPositive Net Change
• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus

by Arpita Dutt Published on December 07,2016

This week, several biotech companies were present at the annual meeting of the American Society of Hematology (ASH) with data on approved and pipeline candidates.

• VRTX Quick QuoteVRTXPositive Net Change
• CELG Quick QuoteCELGPositive Net Change
• AMGN Quick QuoteAMGNNegative Net Change
• ALIOF Quick QuoteALIOFNo Net Change

Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno

by Arpita Dutt Published on November 30,2016

With Johnson & Johnson eyeing Actelion (ALIOF), will mergers and acquisitions pick pace in the biotech sector?

• AMGN Quick QuoteAMGNNegative Net Change
• ALIOF Quick QuoteALIOFNo Net Change
• MNTA Quick QuoteMNTAPositive Net Change
• BIIB Quick QuoteBIIBNegative Net Change

Stock Market News for November 28, 2016

by Zacks Equity Research Published on November 28,2016

• GS Quick QuoteGSPositive Net Change
• AON Quick QuoteAONPositive Net Change
• JNJ Quick QuoteJNJPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change

New Strong Buy Stocks for August 17th

by Indradip Ghosh Published on August 17,2016

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

• CHTR Quick QuoteCHTRNegative Net Change
• LINC Quick QuoteLINCPositive Net Change
• ALIOF Quick QuoteALIOFNo Net Change